Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAP-CABG
NCT01158703Phase 4Terminated
- Start
- Jul 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD). Started Jul 2010; status: terminated.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01158703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158703.